Home - Cytonomics

Pioneering the Future of Genomics

Translating multimodal data into precision neurological insights

Decode genomic, imaging, and immune data; accelerate rare disease diagnosis and clinical trial matching through AI-driven insights curated by our neuroscience experts and patient-owned data framework.🚀

We are a precision neuroscience company composed of neurologists, neuroscience and AI/ML experts advancing the future of rare disease care with multimodal data integration, patient-owned genomic intelligence, and clinical trial acceleration solutions.🚀

About Us

Why Cytonomics is Your Ideal Partner

Empowering patients, neurologists, and researchers to close the gap between rare neurological disease, clinical trials, and real-world therapies.

We are building AI/ML algorithms on rich multimodal and multi-omics datasets—integrating clinical, genomic, imaging, neuroimmunology, and longitudinal outcomes—to identify the right patients for the right study at the right time.

Deep Tech Solutions

Using advanced AI/ML screening tools to match patients with rare neurological conditions to appropriate clinical trials, early-access programs, and investigative studies, reducing time to enrollment and increasing the chance of accessing cutting‑edge therapies

Multi Omics & Precision Medicine

Combining genomics, transcriptomics, proteomics, imaging, and deep clinical phenotyping, our platform uncovers novel disease subtypes, biomarkers, and therapeutic targets that inform next‑generation drugs and personalized treatment strategies for rare neuro disorders.

Data Governance

Patient‑centric data governance model: patients retain ownership of their data, choose how and where it is used, and benefit from transparent consent, granular sharing controls, and value‑sharing models when their data contributes to research, trials, or commercial partnerships

Your genetic blueprint unlocks precision medicine.Understanding your multimodal health data and Integrated analysis identifies disease risk, matches you to clinical trials, and guides personalized therapies that work for your rare neurological condition.

Genetic testing helps identify potential health risks and guides personalised treatment plans.

3KM

From Hospital

5KM

From Research Lab

Advancing Precision Neurology Through AI-Powered Genomics

We are a collective of neuroscience experts committed to closing the gap between rare neurological disease and precision medicine by driving innovation through multimodal data integration, advanced AI/ML algorithms, and patient-centered data ownership.

Future-Ready Genomics

Harnessing cutting-edge technology to revolutionize healthcare and genetic testing."** 🚀

Explore our breakthroughs in genomics and the stories that drive us forward

Read our blogs

We believe in our process and want you to see how we work

See our workflow

Our global team is dedicated to creating groundbreaking genomic solutions.

Meet Our Expert

Focus Areas

Empowering Neuroscience Through AI-Driven Precision

Pioneering a new era of precision neurology for rare neurological disorders through breakthroughs in multimodal data integration, AI/ML analysis, and patient-owned genomic intelligence, our neuroscience experts are building solutions that accelerate diagnosis, clinical trial access, and personalized therapies for rare disorders.

Neurogenetics

Understanding genetic factors that impact fertility, pregnancy, and newborn health. Our experts provide crucial insights into inherited conditions.

Neuroimmunology

Integrating immune insights into neurological care. Our services offer comprehensive neuroimmunology evaluation, counseling, and support for individuals and families affected by immune-mediated neurological disorders.

Precision Neurology

Navigating the complexities of rare neurological disorders requires AI-driven precision. Our proprietary AI/ML algorithms analyze multimodal datasets—genomics, imaging, neuroimmunology, and clinical phenotypes—to enable earlier diagnosis, precise patient screening for clinical trials, and informed treatment decisions that empower patients to access the right therapeutic opportunities.

Rare Disorders

Our Rare Disorders program is accelerating the understanding, diagnosis, and management of uncommon conditions through innovative approaches.